Arthrocare Corp.(NASDAQ : ARTC)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Medical Specialties
|TMO||Thermo Fisher Scientific, Inc.||0.24%||629.10||1.0%||$856.87m|
|ISRG||Intuitive Surgical, Inc.||-3.34%||316.41||0.8%||$444.00m|
|BDX||Becton, Dickinson & Co.||0.74%||243.72||1.0%||$390.88m|
|BSX||Boston Scientific Corp.||-0.83%||39.27||1.0%||$354.96m|
|ALGN||Align Technology, Inc.||-1.90%||613.07||6.4%||$301.87m|
|EW||Edwards Lifesciences Corp.||-1.88%||107.76||0.4%||$257.51m|
|A||Agilent Technologies, Inc.||-1.24%||149.13||1.6%||$244.59m|
|ZBH||Zimmer Biomet Holdings, Inc.||-1.75%||120.78||1.7%||$231.83m|
|IDXX||IDEXX Laboratories, Inc.||-3.30%||579.27||3.8%||$214.30m|
|WST||West Pharmaceutical Services, Inc.||-1.47%||430.95||1.6%||$182.66m|
ArthroCare develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes. Its devices improve many existing surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its internationally patented Coblation (R) technology. This technology precisely dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology including its OPUS (R) line of fixation products as well as re-usable surgical instruments. ArthroCare is leveraging these technologies in order to offer a comprehensive line of surgical devices to capitalize on a multi-billion dollar market opportunity across several surgical specialties, including its two core product areas consisting of Sports Medicine and Ear, Nose, and Throat as well as other areas such as spine, wound care, urology and gynecology.